United States

More than Medicine

Jul 04, 2013
From the Healthcare & Life Sciences Institute

As global healthcare systems evolve to focus on delivering better patient outcomes at lower costs, More than medicine, a new report from KPMG's Global Life Sciences practice, examines opportunities for life sciences companies to use their talents, scale and data to be part of the solution, positioned as a partner in the system rather than a supplier to it.

Strategies for success

The report outlines three practical yet crucial strategies life sciences companies must adapt to thrive in this new reality:

  1. Understand the customer and what they want
  2. Reshape R&D to provide reimbursable drugs and devices that deliver shareholder value
  3. Anticipate shifting power structures in the wider healthcare ecosystem

Leveraging KPMG’s deep global experience in healthcare and life sciences, the report identifies a number of emerging opportunities for life sciences organizations to partner with health systems to create new growth markets and competitive advantages.

Read More than Medicine